Progressive Spread of Beta-amyloid Pathology in an Olfactory-driven Amyloid Precursor Protein Mouse Model.


Journal

Neuroscience
ISSN: 1873-7544
Titre abrégé: Neuroscience
Pays: United States
ID NLM: 7605074

Informations de publication

Date de publication:
15 04 2023
Historique:
received: 20 10 2022
revised: 04 12 2022
accepted: 13 01 2023
pmc-release: 15 04 2024
medline: 3 4 2023
pubmed: 31 1 2023
entrez: 30 1 2023
Statut: ppublish

Résumé

Years before Alzheimer's disease (AD) is diagnosed, patients experience an impaired sense of smell, and β-amyloid plaques accumulate within the olfactory mucosa and olfactory bulb (OB). The olfactory vector hypothesis proposes that external agents cause β-amyloid to aggregate and spread from the OB to connected downstream brain regions. To reproduce the slow accumulation of β-amyloid that occurs in human AD, we investigated the progressive accumulation of β-amyloid across the brain using a conditional mouse model that overexpresses a humanized mutant form of the amyloid precursor protein (hAPP) in olfactory sensory neurons. Using design-based stereology, we show the progressive accumulation of β-amyloid plaques within the OB and cortical olfactory regions with age. We also observe reduced OB volumes in these mice when hAPP expression begins prior-to but not post-weaning which we tracked using manganese-enhanced MRI. We therefore conclude that the reduced OB volume does not represent progressive degeneration but rather disrupted OB development. Overall, our data demonstrate that hAPP expression in the olfactory epithelium can lead to the accumulation and spread of β-amyloid through the olfactory system into the hippocampus, consistent with an olfactory system role in the early stages of β-amyloid-related AD progression.

Identifiants

pubmed: 36716914
pii: S0306-4522(23)00013-1
doi: 10.1016/j.neuroscience.2023.01.009
pmc: PMC10065898
mid: NIHMS1869385
pii:
doi:

Substances chimiques

Amyloid beta-Protein Precursor 0
Amyloid beta-Peptides 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113-124

Subventions

Organisme : Intramural NIH HHS
ID : Z01 NS002989
Pays : United States

Informations de copyright

Published by Elsevier Ltd.

Références

J Neurosci. 2011 Sep 28;31(39):13699-704
pubmed: 21957232
J Exp Med. 2016 Aug 22;213(9):1759-78
pubmed: 27503075
Ann Neurol. 2010 Apr;67(4):462-9
pubmed: 20437581
Neuroimage. 2015 Sep;118:183-92
pubmed: 26021215
J Alzheimers Dis. 2009;17(1):213-21
pubmed: 19494444
Commun Biol. 2022 Jan 24;5(1):88
pubmed: 35075270
Neuroreport. 2001 Feb 12;12(2):285-8
pubmed: 11209936
Clin Microbiol Rev. 2014 Oct;27(4):691-726
pubmed: 25278572
Neurobiol Dis. 2018 May;113:1-10
pubmed: 29414379
eNeuro. 2016 Aug 01;3(4):
pubmed: 27517085
Neurology. 2002 Jun 25;58(12):1791-800
pubmed: 12084879
Proc Natl Acad Sci U S A. 1990 Feb;87(4):1561-5
pubmed: 1689489
J Alzheimers Dis. 2005 Apr;7(2):149-57; discussion 173-80
pubmed: 15851853
Front Mol Neurosci. 2021 Dec 21;14:780352
pubmed: 34992523
Mol Neurodegener. 2011 Dec 28;6:88
pubmed: 22204380
Nat Commun. 2012;3:1009
pubmed: 22910355
Nature. 2007 Jan 11;445(7124):168-76
pubmed: 17151600
Brain Sci. 2021 Jul 30;11(8):
pubmed: 34439629
Sci Rep. 2012;2:231
pubmed: 22355745
Mol Neurodegener. 2007 Nov 15;2:22
pubmed: 18005427
Neurobiol Aging. 1995 May-Jun;16(3):271-8; discussion 278-84
pubmed: 7566337
Cell. 2007 Nov 30;131(5):1009-17
pubmed: 18045541
Mol Neurodegener. 2017 Dec 22;12(1):89
pubmed: 29273078
Neurobiol Aging. 2009 May;30(5):838-41
pubmed: 17875348
Mol Neurobiol. 2018 Feb;55(2):1703-1713
pubmed: 28211008
J Alzheimers Dis. 2015;48(2):395-402
pubmed: 26402003
Handb Clin Neurol. 2018;153:303-319
pubmed: 29887142
Neuroimage. 2017 Sep;158:232-241
pubmed: 28669915
Acta Neuropathol Commun. 2019 Dec 30;7(1):221
pubmed: 31888771
J Neurosci. 2013 Jul 24;33(30):12208-17
pubmed: 23884929
Am J Psychiatry. 2000 Sep;157(9):1399-405
pubmed: 10964854
Neuroscience. 1980;5(7):1239-52
pubmed: 7402467
J Neurosci. 2010 Jul 7;30(27):9172-80
pubmed: 20610751
Virus Res. 2015 Sep 2;207:106-12
pubmed: 25575736
Ann Neurol. 2008 Jan;63(1):7-15
pubmed: 18232016
Acta Neuropathol Commun. 2020 Jul 14;8(1):109
pubmed: 32665027
Neuron. 2004 May 27;42(4):553-66
pubmed: 15157418
Brain Pathol. 2022 Mar;32(2):e13033
pubmed: 34704631
J Neurosci. 1997 Oct 1;17(19):7433-40
pubmed: 9295389
Neurobiol Dis. 2018 Jan;109(Pt B):226-248
pubmed: 28011307
PLoS Biol. 2020 Jul 14;18(7):e3000411
pubmed: 32663221
PLoS Med. 2005 Dec;2(12):e355
pubmed: 16279840

Auteurs

Helen C Murray (HC)

Department of Anatomy and Medical Imaging and Centre for Brain Research, Faculty of Medical and Health Science, University of Auckland, Auckland 1023, New Zealand; Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: h.murray@auckland.ac.nzKore.

Galit Saar (G)

Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: sgalit@technion.ac.il.

Li Bai (L)

Circuits, Synapses and Molecular Signaling Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: li.bai@nih.gov.

Nadia Bouraoud (N)

Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: Nadia.Bouraoud@nih.gov.

Stephen Dodd (S)

Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: doddst@ninds.nih.gov.

Blake Highet (B)

Department of Anatomy and Medical Imaging and Centre for Brain Research, Faculty of Medical and Health Science, University of Auckland, Auckland 1023, New Zealand. Electronic address: blake.highet@utah.edu.

Brigid Ryan (B)

Department of Anatomy and Medical Imaging and Centre for Brain Research, Faculty of Medical and Health Science, University of Auckland, Auckland 1023, New Zealand. Electronic address: b.ryan@auckland.ac.nz.

Maurice A Curtis (MA)

Department of Anatomy and Medical Imaging and Centre for Brain Research, Faculty of Medical and Health Science, University of Auckland, Auckland 1023, New Zealand. Electronic address: m.curtis@auckland.ac.nz.

Alan Koretsky (A)

Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: tskyA@ninds.nih.gov.

Leonardo Belluscio (L)

Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: bellusciol@hhmi.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH